Skip to main content
. Author manuscript; available in PMC: 2019 Mar 26.
Published in final edited form as: Ocul Surf. 2018 Jul 7;16(4):463–469. doi: 10.1016/j.jtos.2018.07.004

Fig. 4.

Fig. 4.

Effect of PPARγ signaling on lipid production after 4d in culture. (A) Control cells cultured in DMEM/F12 with EGF. (B) Cells treated with rosiglitazone (30 μM) alone produced a marked increase in lipid droplets. (C) Cells treated with T0070907 (10 μM), a specific PPARγ antagonist showed no lipid droplets. (D) Cells treated with T0070907 and rosiglitazone showed a significant suppression of lipid droplet accumulation. (E) Bar graphs showing that there was a significant difference in lipid production between cells treated with rosiglitazone and cells cultured under all other condition (*: P < 0.001 for comparison between cells cultured with rosiglitazone and all other conditions).